Transaction in Own Shares

RNS Number : 7517N

PureTech Health PLC

25 January 2023

 

25 January 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase:	24 January 2023
Number of ordinary shares purchased:	842
Highest price paid per share:	264.00p
Lowest price paid per share:	260.00p
Volume weighted average price paid per share:	261.79p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 10,596,189 ordinary shares in treasury and has 278,871,970 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 278 ,871,970 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 26 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that will soon be filed for FDA approval, as of the most recent update by the Company. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

[e-mail]

Individual Transactions

Transaction Date	Transaction Time	Volume	Price (GBp)	Platform	Transaction Reference Number
24/01/2023	09:44:20	3	264	TRQX	00335937430TRLO1.1.1
24/01/2023	09:41:34	3	264	TRQX	00335936487TRLO1.1.1
24/01/2023	09:37:52	78	263.5	XLON	00335935713TRLO1.1.1
24/01/2023	09:37:26	11	263	CHIX	00335935640TRLO1.1.1
24/01/2023	09:36:15	6	261.5	AQXE	00335935253TRLO1.1.1
24/01/2023	09:35:10	9	261	BATE	00335934960TRLO1.1.1
24/01/2023	09:34:20	3	263	TRQX	00335934813TRLO1.1.1
24/01/2023	09:34:03	89	261.5	XLON	00335934760TRLO1.1.1
24/01/2023	09:31:41	12	262	CHIX	00335934023TRLO1.1.1
24/01/2023	09:31:41	87	261.5	XLON	00335934022TRLO1.1.1
24/01/2023	09:30:06	3	263	TRQX	00335933527TRLO1.1.1
24/01/2023	09:29:24	6	262.5	AQXE	00335933132TRLO1.1.1
24/01/2023	09:29:04	12	262	BATE	00335933024TRLO1.1.1
24/01/2023	09:18:14	7	261	AQXE	00335926753TRLO1.1.1
24/01/2023	09:18:13	12	262	BATE	00335926745TRLO1.1.1
24/01/2023	09:18:13	3	263	TRQX	00335926746TRLO1.1.1
24/01/2023	09:17:29	5	261.5	AQXE	00335926117TRLO1.1.1
24/01/2023	09:17:28	12	262	CHIX	00335926091TRLO1.1.1
24/01/2023	09:10:25	91	262	XLON	00335921087TRLO1.1.1
24/01/2023	09:10:25	91	262	XLON	00335921086TRLO1.1.1
24/01/2023	09:06:17	3	263	TRQX	00335919790TRLO1.1.1
24/01/2023	09:05:20	172	260	XLON	00335919638TRLO1.1.1
24/01/2023	09:04:18	3	263	TRQX	00335919153TRLO1.1.1
24/01/2023	09:04:18	9	263	TRQX	00335919154TRLO1.1.1
24/01/2023	09:04:18	18	263	AQXE	00335919151TRLO1.1.1
24/01/2023	09:04:18	6	263	AQXE	00335919152TRLO1.1.1
24/01/2023	09:03:24	33	263	BATE	00335918996TRLO1.1.1
24/01/2023	09:03:24	11	263	BATE	00335918995TRLO1.1.1
24/01/2023	09:03:24	20	263	CHIX	00335918992TRLO1.1.1
24/01/2023	09:03:24	12	263	CHIX	00335918991TRLO1.1.1
24/01/2023	09:02:42	1	263	CHIX	00335918853TRLO1.1.1
24/01/2023	09:02:42	6	263	CHIX	00335918852TRLO1.1.1
24/01/2023	09:02:34	5	263	CHIX	00335918814TRLO1.1.1

 

END

 

 

POSFFFFILFISFIV